Optimization of Eugenol, Camphor, and Terpineol Mixture Using Simplex-Centroid Design for Targeted Inhibition of Key Antidiabetic Enzymes
Current Issues in Molecular Biology · 02.07.2025 · 47 (7) · 512
DOI: 10.3390/cimb47070512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 02.07.2025. Verfasst von Amine Elbouzidi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Ou…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The optimization of bioactive compound mixtures is critical for enhancing pharmacological efficacy. This study investigates, for the first time, the combined effects of eugenol, camphor, and terpineol, focusing on their half-maximal inhibitory concentrations (IC50) across multiple biological responses related to diabetes management. Using a mixture design approach, the objective was to determine the optimal formulation that maximizes bioactivity and validate the findings experimentally. A simplex-centroid design was applied to evaluate the combined effects of eugenol, camphor, and terpineol on AAI IC50, AGI IC50, LIP IC50, and ALR IC50 responses. The desirability function was used to determine the ideal composition. The optimized formulation was experimentally validated using in vitro assays, and IC50 values were measured for each response using standard protocols. Results: The optimal formulation identified was 44% eugenol, 0.19% camphor, and 37% terpineol, yielding IC50 values of 10.38 µg/mL (AAI), 62.22 µg/mL (AGI), 3.42 µg/mL (LIP), and 49.58 µg/mL (ALR). The desirability score (0.99) confirmed the effectiveness of the optimized blend. Experimental validation of the optimal mixture resulted in IC50 values of 11.02 µg/mL (AAI), 60.85 µg/mL (AGI), 3.75 µg/mL (LIP), and 50.12 µg/mL (ALR), showing less than 10% deviation from predicted values, indicating high model accuracy. This study confirms the combined potential of eugenol, camphor, and terpineol, with eugenol and terpineol significantly enhancing bioactivity. The validated formulation demonstrates potential for pharmaceutical and cosmeceutical applications. Future research should explore mechanistic interactions, bioavailability, and in vivo efficacy to support the development of optimized natural compound-based therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Oujda 60000, Morocco.
- Laboratory of Microbial Biotechnology and Bioactive Molecules, Faculty of Sciences and Technologies, Sidi Mohamed Ben Abdellah University, Imouzzer Road, Fez P.O. Box 2202, Morocco.
- Laboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Faculty of Sciences, Mohammed First University, Boulevard Mohamed VI, B.P. 717, Oujda 60000, Morocco.
- Centre de l'Oriental des Sciences et Technologies de l'Eau et de l'Environnement (COSTEE), Université Mohammed Premier, Oujda 60000, Morocco.
- Faculty of Medicine and Pharmacy, Ibn Zohr University, Guelmim 81000, Morocco.
ORCID-Profile: Amine Elbouzidi, Mohamed Jeddi, Abdellah Baraich, Mohamed Taibi, Mounir Haddou, Naoufal El Hachlafi, Meryem Idrissi Yahyaoui, Mohamed Addi
Zitieren
APA
Elbouzidi, A., Jeddi, M., Baraich, A., Taibi, M., Haddou, M., El Hachlafi, N., Yahyaoui, M. I., Bellaouchi, R., El Guerrouj, B., Chaabane, K., & Addi, M. (2025). Optimization of Eugenol, Camphor, and Terpineol Mixture Using Simplex-Centroid Design for Targeted Inhibition of Key Antidiabetic Enzymes. Current Issues in Molecular Biology, 47(7), 512. https://doi.org/10.3390/cimb47070512
Vancouver
Elbouzidi A, Jeddi M, Baraich A, Taibi M, Haddou M, El Hachlafi N, et al. Optimization of Eugenol, Camphor, and Terpineol Mixture Using Simplex-Centroid Design for Targeted Inhibition of Key Antidiabetic Enzymes. Current Issues in Molecular Biology. 2025;47(7):512. doi:10.3390/cimb47070512
BibTeX
@article{Elbouzidi2025,
author = {Elbouzidi, Amine and Jeddi, Mohamed and Baraich, Abdellah and Taibi, Mohamed and Haddou, Mounir and El Hachlafi, Naoufal and Yahyaoui, Meryem Idrissi and Bellaouchi, Reda and El Guerrouj, Bouchra and Chaabane, Khalid and Addi, Mohamed},
title = {Optimization of Eugenol, Camphor, and Terpineol Mixture Using Simplex-Centroid Design for Targeted Inhibition of Key Antidiabetic Enzymes},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {7},
pages = {512},
doi = {10.3390/cimb47070512}
}
EUVIMED